Xiong, Ying
Karlsson, Robert http://orcid.org/0000-0002-8949-2587
Song, Jie http://orcid.org/0000-0002-7357-2136
Kowalec, Kaarina http://orcid.org/0000-0003-3928-9879
Rück, Christian http://orcid.org/0000-0002-8742-0168
Sigström, Robert
Jonsson, Lina
Clements, Caitlin C. http://orcid.org/0000-0003-2278-6465
Andersson, Evelyn
Boberg, Julia
Lewis, Cathryn M. http://orcid.org/0000-0002-8249-8476
Sullivan, Patrick F.
Landén, Mikael http://orcid.org/0000-0002-4496-6451
Article History
Received: 6 February 2023
Revised: 15 September 2023
Accepted: 20 September 2023
First Online: 28 September 2023
Competing interests
: PFS is a consultant and shareholder for Neumora Therarapeutics. ML declares that he has received lecture honoraria from Lundbeck Pharmaceutical and served as a consultant for AstraZeneca. CML sits on the SAB for Myriad Neuroscience. All other authors report no biomedical financial interests or potential conflicts of interest related to this work.